Dopamine agonists (DAs) represent a mainstay of therapy for hyperprolactinemia and
prolactinomas. The widespread use of DAs, including bromocriptine, cabergoline and (in …

Objective To familiarize health care providers with diagnosis and treatment of binge-eating
disorder (BED), a common comorbidity of type 2 diabetes (T2DM). Methods Literature review …

Context There are growing reports of dopamine agonist (DA)-induced impulse control
disorders (ICDs) in hyperprolactinemic patients. However, the magnitude of this risk and …

Dopamine agonists are the treatment of choice for all patients with prolactinomas. They are
generally safe, effective, and well-tolerated. However, a link between their use and the …

Dopamine agonists (DAs) represent a cornerstone in the management of patients with
hyperprolactinemia and have an important role in the treatment of neurologic disorders …

The complex impacts of prolonged morphine exposure continue to be a significant focus in
the expanding area of addiction studies. This research investigates the effectiveness of a …

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline Page
1 Review began 05/22/2023 Review ended 05/29/2023 Published 06/02/2023 © Copyright …

6School of Psychology, University of Adelaide, Adelaide, Australia; 7School of Medicine,
Sydney, The University of Notre Dame, Australia; 8Department of Diabetes and …

Hyperprolactinaemia is the commonest pituitary endocrinopathy. The degree of prolactin
elevation is integral to patient assessment, necessitating vigilance in serum prolactin …

Obsessive compulsive disorder secondary to the administration of cabergoline or Dostinex®
is rare but serious because it adversely affects the personal and social life of the individual …